Summary
- Current Price
- As of today, AVTX price is $13.89, down -0.43% on
- Current Price All-Time High
- AVTX price is currently -99.94% below its historical high of $22,032.00 set on
- Market Cap
- AVTX current market cap is $257M, up +176.01% over the past 365 days
- PE Ratio
- AVTX PE ratio is unknown
- Revenue
- AVTX current annual revenue is $59.00K, down -86.62% year-over-year
- Next Earnings
- As of today, the next earnings release for AVTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Avalo Therapeutics, Inc. |
| Ticker | NASDAQ: AVTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | avalotx.com |
| Employees | 23 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $13.89 | ||
| Price, 1D Change | -0.43% | |
| $257M | ||
| - | ||
| - | ||
| 0.83 | ||
| $59K | ||
| Revenue, 1Y Change | -86.62% | |
| -$5.84 | ||
| EPS, 1Y Change | +72.08% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:240 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CERC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$5.84 | ||
| EPS Estimate | N/A | -$3.21 |
| EPS Est. Change | N/A | +45.02% |
| $59.00K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $13.89 | ||
| Price Target | - | $39.00 |
| Price Tgt. Change | - | +180.78% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.92 | -$20.91 | -261.83% | |
| -$5.91 | -$5.84 | +1.29% | |
| -$3.21 | N/A | +45.02% | |
| -$2.83 | N/A | +51.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $224.50K | $441.00K | +96.44% | |
| - | $59.00K | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +59.11% | ||
| -96.67% | ||
| +176.01% | ||
| +1,019.57% | ||
| -86.62% | ||
| -99.67% | ||
| +72.08% | ||
| +99.45% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $13.89 | ||
| $13.09 | ||
| SMA 200 vs Price | -5.78% | |
| $15.50 | ||
| SMA 50 vs Price | +11.57% | |
| 0.83 | ||
| $1.18 | ||
| 37.75 | ||
| 47.11% | ||
| 84.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $59.00K | ||
| -$5.84 | ||
| -$285.00K | ||
| -483.05% | ||
| -$72.93M | ||
| -123.60% | ||
| -$78.26M | ||
| -132.64% | ||
| -$72.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 8.14 | ||
| 8.14 | ||
| - | ||
| 3 | ||
| -1.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4,358.34 | ||
| 3.10 | ||
| -2.22 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $83.05M | ||
| $98.37M | ||
| $117.70M | ||
| $105.29M | ||
| $34.65M | ||
| $12.94M | ||
| $2.43M | ||
| $392.00K | ||
| $137.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $78.32M | ||
| $72.64M | ||
| $344.00K | ||
| $0.00 | ||
| $344.00K | ||
| $0.00 | ||
| $165.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$51.46M | ||
| -$81.72M | ||
| $14.59M | ||
| $0.00 | ||
| -$51.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| Mizuho | ||
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | ||
| Stifel | ||
| Jefferies |
Analyst sentiment
Institutional ownership
Screeners with AVTX
FAQ
What is the ticker symbol for Avalo Therapeutics, Inc.?
The ticker symbol for Avalo Therapeutics, Inc. is NASDAQ:AVTX
Does Avalo Therapeutics, Inc. pay dividends?
No, Avalo Therapeutics, Inc. does not pay dividends
What sector is Avalo Therapeutics, Inc. in?
Avalo Therapeutics, Inc. is in the Healthcare sector
What industry is Avalo Therapeutics, Inc. in?
Avalo Therapeutics, Inc. is in the Biotechnology industry
What country is Avalo Therapeutics, Inc. based in?
Avalo Therapeutics, Inc. is headquartered in United States
When did Avalo Therapeutics, Inc. go public?
Avalo Therapeutics, Inc. initial public offering (IPO) was on October 14, 2015
Is Avalo Therapeutics, Inc. in the S&P 500?
No, Avalo Therapeutics, Inc. is not included in the S&P 500 index
Is Avalo Therapeutics, Inc. in the NASDAQ 100?
No, Avalo Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Avalo Therapeutics, Inc. in the Dow Jones?
No, Avalo Therapeutics, Inc. is not included in the Dow Jones index
When was Avalo Therapeutics, Inc. last earnings report?
Avalo Therapeutics, Inc.'s most recent earnings report was on November 7, 2024
When does Avalo Therapeutics, Inc. report earnings?
The date for Avalo Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AVTX Official Website www.avalotx.com
- AVTX Profile on Yahoo Finance finance.yahoo.com/quote/AVTX
- AVTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avtx